|
Delayed
Australian S.E.
06:43:05 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3300 AUD | -4.35% |
|
-5.71% | -49.23% |
| 08-31 | Recce Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-30 | Recce Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.99M | - | ||||
| 1,028B | |||||
| 651B | - | ||||
| 466B | |||||
| 346B | |||||
| 266B |
Select your edition
All financial news and data tailored to specific country editions
